94 related articles for article (PubMed ID: 12766191)
1. Neuroendocrine-immune surveillance of osteosarcoma: emerging hypothesis.
Prolo P; Chiappelli F; Bernard G; Fiala M; Ibarra A; Sartori ML; Dovio A; Angeli A
J Dent Res; 2003 Jun; 82(6):417-21. PubMed ID: 12766191
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of selected parameters of cellular immunity in children with osteosarcoma at diagnosis].
Markiewicz K; Zeman K; Kozar A; Gołębiowska-Wawrzyniak M; Woźniak W
Med Wieku Rozwoj; 2012; 16(3):212-21. PubMed ID: 23378399
[TBL] [Abstract][Full Text] [Related]
4. [Studies on various parameters of the T-dependent lymphocyte system in the course of osteosarcoma].
Marinoni I; Torelli L
Boll Ist Sieroter Milan; 1976; 55(6):548-52. PubMed ID: 1088075
[TBL] [Abstract][Full Text] [Related]
5. Impaired lymphocyte responsiveness in osteosarcoma.
Twomey PL; Chretien PB
J Surg Res; 1975 May; 18(5):551-4. PubMed ID: 1055278
[No Abstract] [Full Text] [Related]
6. [Possibilities of study of the main cytokines of the immune system in patients with osteogenic sarcoma].
Navruzov SN; Polatova DSh; Gel'dieva MS; Nurieva ÉI
Vopr Onkol; 2013; 59(5):599-602. PubMed ID: 24260887
[TBL] [Abstract][Full Text] [Related]
7. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE
Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589
[TBL] [Abstract][Full Text] [Related]
8. [Modifications of B lymphocyte membrane markers in patients with osteosarcoma].
Torelli L; Marinoni I
Boll Ist Sieroter Milan; 1976; 55(6):553-9. PubMed ID: 798595
[TBL] [Abstract][Full Text] [Related]
9. Immunologic aspects of osteosarcoma and their application to therapy. A preliminary report.
Marsh B; Flynn L; Enneking W
J Bone Joint Surg Am; 1972 Oct; 54(7):1367-97. PubMed ID: 4120092
[No Abstract] [Full Text] [Related]
10. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST
Vopr Onkol; 1984; 30(10):19-25. PubMed ID: 6093380
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway.
Li Z; Xu Q; Peng H; Cheng R; Sun Z; Ye Z
Int Immunopharmacol; 2011 Apr; 11(4):496-503. PubMed ID: 21238618
[TBL] [Abstract][Full Text] [Related]
12. [Selected immunologic indicators in malignant bone tumors].
Keleová A; Huraj E; Jahnová E; Janota S; Nyulassy S
Acta Chir Orthop Traumatol Cech; 1990 Feb; 57(1):77-88. PubMed ID: 2336911
[TBL] [Abstract][Full Text] [Related]
13. Immunocompetence of lymphocytes from osteosarcoma patients.
McMaster JH; Weinert CR; Dickens DR
Lancet; 1973 Apr; 1(7806):781-2. PubMed ID: 4120769
[No Abstract] [Full Text] [Related]
14. Telangiectatic osteosarcoma.
Sangle NA; Layfield LJ
Arch Pathol Lab Med; 2012 May; 136(5):572-6. PubMed ID: 22540307
[TBL] [Abstract][Full Text] [Related]
15. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
Xie GL
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
Kosmiadi GA; Grigor'eva MP; Govallo VI
Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
[TBL] [Abstract][Full Text] [Related]
17. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma.
Heymann MF; Lézot F; Heymann D
Cell Immunol; 2019 Sep; 343():103711. PubMed ID: 29117898
[TBL] [Abstract][Full Text] [Related]
18. [Decreased count of small lymphocytes in the blood of patients with malignant bone tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Efimtseva NN; Baranovskaia VT
Vopr Onkol; 1987; 33(9):15-21. PubMed ID: 3499033
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of APO-1/Fas and interleukin-1beta-converting enzyme in osteosarcoma correlate with response to chemotherapy.
Holzer G; Trieb K; Koschat M; Blahovec H; Kotz R
Anticancer Res; 2002; 22(3):1869-72. PubMed ID: 12168884
[TBL] [Abstract][Full Text] [Related]
20. HLA phenotypes in patients who have osteosarcoma.
Shimizu T; Chigira M; Nagase M; Watanabe H; Udagawa E
J Bone Joint Surg Am; 1990 Jan; 72(1):68-70. PubMed ID: 2295675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
